Experts from industry and government will discuss a variety of important diagnostics issues during a conference this week in Washington, D.C. The program will take place June 12–13 at L’Enfant Plaza Hotel. Sponsored by AdvaMed, the interactive sessions will cover topics such as 510(k) submissions, CLIA waivers, and case studies. An industry overview with Andy Fish, executive director of AdvaMedDx, is also on the agenda. Other speakers include Mark Del Vecchio, vice president of regulatory affairs and quality assurance for Nanosphere; Ann Chappie of CDRH/OIVD; and Guido Brink, vice president of regulatory affairs and quality assurance for Agendia. Read more at AdvaMed's Website.